CRDF vs CRDL

Cardiff Oncology, Inc. vs Cardiol Therapeutics Inc. — Valuation Comparison 2026

CRDF

Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
Quality
5.9
out of 10
Value Trap
30
LOW
Price
$1.90
Last close
Models
9/13
Active
VS

CRDL

Biological Products, (No Diagnostic Substances)
Cardiol Therapeutics Inc.
Quality
6.4
out of 10
Value Trap
12
SAFE
Price
$1.22
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType CRDF Fair ValueCRDF Upside CRDL Fair ValueCRDL Upside
Bayesian DCF Intrinsic $0.57 -70.2% $0.42 -65.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.06 -96.2% $0.01 -98.9%
Dynamic NAV Asset-Based $0.83 -56.3% $0.17 -86.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CRDF vs CRDL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CRDF vs CRDL — Which Stock Is More Undervalued?

CRDL scores higher with a 6.4/10 quality rating vs CRDF's 5.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cardiff Oncology, Inc. (CRDF) and Cardiol Therapeutics Inc. (CRDL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CRDF currently trades at $1.90 with a QOC of 5.9/10, while CRDL trades at $1.22 with a QOC of 6.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).